Afterload Reduction in Hypertension with CHF Due to Diastolic Dysfunction
ACE inhibitors should be the first-line therapy for afterload reduction in patients with hypertension and CHF exacerbation due to diastolic dysfunction. 1
First-Line Therapy: ACE Inhibitors
ACE inhibitors are the preferred agents for several important reasons:
- They effectively reduce afterload by decreasing systemic vascular resistance
- They have been shown to improve outcomes in patients with heart failure
- They have beneficial effects on LV fibrosis, which is particularly important in diastolic dysfunction 1
- They effectively lower blood pressure without negative inotropic effects
- The 2007 AHA guidelines specifically recommend ACE inhibitors as first-line therapy for hypertension in patients with heart failure 1
Specific ACE Inhibitor Recommendation:
- Lisinopril is an excellent choice with proven efficacy in heart failure 2, 3
- Starting dose should be low (2.5-5mg) and gradually titrated upward with careful monitoring 2
- Maximum benefits are seen at higher doses (20-35mg daily) as demonstrated in the ATLAS study 3
Second-Line Options: ARBs
If ACE inhibitors are not tolerated (due to cough or angioedema):
- Angiotensin receptor blockers (ARBs) like candesartan or valsartan are appropriate alternatives
- Studies have shown equivalence of benefit between ACE inhibitors and ARBs in heart failure 1
- ARBs may be particularly beneficial in patients with diastolic dysfunction 4
Additional Therapies
Diuretics
- Thiazide diuretics should be used for BP control and to reverse volume overload 1
- In severe heart failure or renal impairment, loop diuretics may be necessary 1
- Diuretics should be used together with an ACE inhibitor or ARB 1
Beta-Blockers
- Beta-blockers (specifically carvedilol, metoprolol succinate, or bisoprolol) should be added to the regimen 1
- These agents have been shown to improve outcomes in heart failure 1
Aldosterone Antagonists
- Consider adding spironolactone or eplerenone in severe heart failure 1
- The TOPCAT study is evaluating spironolactone specifically for diastolic heart failure 4
Medications to Avoid
Several medications should be avoided in patients with hypertension and heart failure:
- Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) due to negative inotropic properties 1
- Alpha-blockers like doxazosin (increased risk of heart failure) 1
- Clonidine and moxonidine (potential for increased mortality) 1
- Nifedipine (particularly in patients with outflow obstruction) 1, 5
Blood Pressure Targets
- Target BP should be <130/80 mmHg 1
- Consider lowering BP even further to <120/80 mmHg in selected patients 1
- BP should be lowered gradually to avoid hypoperfusion, particularly in elderly patients 1
Treatment Algorithm
- Start with ACE inhibitor (e.g., lisinopril) at low dose
- Add diuretic therapy (thiazide or loop diuretic depending on severity)
- Titrate ACE inhibitor to optimal dose
- Add beta-blocker (carvedilol, metoprolol succinate, or bisoprolol)
- Consider aldosterone antagonist in severe cases
- If ACE inhibitor not tolerated, substitute with ARB
Monitoring and Precautions
- Monitor renal function and potassium levels closely, especially when initiating therapy
- Start with low doses and titrate gradually
- Be cautious with excessive BP reduction that may precipitate renal, cerebral, or coronary ischemia 5
- In patients with elevated diastolic BP and evidence of myocardial ischemia, lower BP slowly 1
- Elderly patients may be more susceptible to hypotension and should be monitored carefully 5
By following this approach, you can effectively manage afterload reduction in patients with hypertension and CHF exacerbation due to diastolic dysfunction, improving both symptoms and outcomes.